Leap Therapeutics Statistics
Total Valuation
LPTX has a market cap or net worth of $99.10 million. The enterprise value is $36.66 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, before market open.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
LPTX has 38.26 million shares outstanding. The number of shares has increased by 105.89% in one year.
Current Share Class | 38.26M |
Shares Outstanding | 38.26M |
Shares Change (YoY) | +105.89% |
Shares Change (QoQ) | +5.33% |
Owned by Insiders (%) | 0.93% |
Owned by Institutions (%) | 25.83% |
Float | 25.84M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.02 |
P/TBV Ratio | 2.02 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.97, with a Debt / Equity ratio of 0.01.
Current Ratio | 3.97 |
Quick Ratio | 3.95 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -107.18% and return on invested capital (ROIC) is -70.64%.
Return on Equity (ROE) | -107.18% |
Return on Assets (ROA) | -58.05% |
Return on Capital (ROIC) | -70.64% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.20M |
Employee Count | 54 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, LPTX has paid $708,000 in taxes.
Income Tax | 708,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.53% in the last 52 weeks. The beta is 0.22, so LPTX's price volatility has been lower than the market average.
Beta (5Y) | 0.22 |
52-Week Price Change | +41.53% |
50-Day Moving Average | 2.93 |
200-Day Moving Average | 2.66 |
Relative Strength Index (RSI) | 37.23 |
Average Volume (20 Days) | 445,409 |
Short Selling Information
The latest short interest is 1.01 million, so 2.64% of the outstanding shares have been sold short.
Short Interest | 1.01M |
Short Previous Month | 723,536 |
Short % of Shares Out | 2.64% |
Short % of Float | 3.90% |
Short Ratio (days to cover) | 2.68 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -68.78M |
Pretax Income | -53.37M |
Net Income | -64.82M |
EBITDA | -68.77M |
EBIT | -68.78M |
Earnings Per Share (EPS) | -$1.91 |
Full Income Statement Balance Sheet
The company has $62.82 million in cash and $376,000 in debt, giving a net cash position of $62.45 million or $1.63 per share.
Cash & Cash Equivalents | 62.82M |
Total Debt | 376,000 |
Net Cash | 62.45M |
Net Cash Per Share | $1.63 |
Equity (Book Value) | 48.95M |
Book Value Per Share | 1.28 |
Working Capital | 47.72M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -55.17M |
Capital Expenditures | n/a |
Free Cash Flow | -55.17M |
FCF Per Share | -$1.44 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LPTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -105.89% |
Shareholder Yield | -105.89% |
Earnings Yield | -65.41% |
FCF Yield | -55.67% |
Analyst Forecast
The average price target for LPTX is $8.63, which is 233.21% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.63 |
Price Target Difference | 233.21% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -24.20% |
Stock Forecasts Stock Splits
The last stock split was on June 21, 2023. It was a reverse split with a ratio of 0.1:1.
Last Split Date | Jun 21, 2023 |
Split Type | Reverse |
Split Ratio | 0.1:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |